TSE:7779

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

CYBERDYNE Inc. manufactures and sells medical devices in Japan. More Details


Snowflake Analysis

High growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has CYBERDYNE's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 7779 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 7779's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of JP stocks.


Market Performance


7 Day Return

2.0%

7779

-3.9%

JP Medical Equipment

-0.1%

JP Market


1 Year Return

19.1%

7779

19.9%

JP Medical Equipment

7.3%

JP Market

Return vs Industry: 7779 matched the JP Medical Equipment industry which returned 19.9% over the past year.

Return vs Market: 7779 exceeded the JP Market which returned 7.3% over the past year.


Shareholder returns

7779IndustryMarket
7 Day2.0%-3.9%-0.1%
30 Day-11.4%-1.2%3.3%
90 Day-12.3%8.7%12.5%
1 Year19.1%19.1%20.9%19.9%9.9%7.3%
3 Year-67.4%-67.4%64.6%59.9%5.3%-2.1%
5 Year-66.2%-66.2%121.3%110.7%54.1%36.7%

Long-Term Price Volatility Vs. Market

How volatile is CYBERDYNE's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CYBERDYNE undervalued compared to its fair value and its price relative to the market?

1128.21x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 7779 (¥666) is trading above our estimate of fair value (¥433.89)

Significantly Below Fair Value: 7779 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 7779 is poor value based on its PE Ratio (1128.2x) compared to the JP Medical Equipment industry average (26.5x).

PE vs Market: 7779 is poor value based on its PE Ratio (1128.2x) compared to the JP market (17.5x).


Price to Earnings Growth Ratio

PEG Ratio: 7779 is poor value based on its PEG Ratio (17.9x)


Price to Book Ratio

PB vs Industry: 7779 is overvalued based on its PB Ratio (3.2x) compared to the JP Medical Equipment industry average (2.2x).


Next Steps

Future Growth

How is CYBERDYNE forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

62.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7779's forecast earnings growth (62.9% per year) is above the savings rate (0%).

Earnings vs Market: 7779's earnings (62.9% per year) are forecast to grow faster than the JP market (17.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 7779's revenue (38% per year) is forecast to grow faster than the JP market (5.6% per year).

High Growth Revenue: 7779's revenue (38% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7779's Return on Equity is forecast to be low in 3 years time (2.2%).


Next Steps

Past Performance

How has CYBERDYNE performed over the past 5 years?

24.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 7779 has a large one-off gain of ¥860.0M impacting its September 30 2020 financial results.

Growing Profit Margin: 7779 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 7779 has become profitable over the past 5 years, growing earnings by 24% per year.

Accelerating Growth: 7779 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 7779 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-11.4%).


Return on Equity

High ROE: 7779's Return on Equity (0.3%) is considered low.


Next Steps

Financial Health

How is CYBERDYNE's financial position?


Financial Position Analysis

Short Term Liabilities: 7779's short term assets (¥28.0B) exceed its short term liabilities (¥489.0M).

Long Term Liabilities: 7779's short term assets (¥28.0B) exceed its long term liabilities (¥3.1B).


Debt to Equity History and Analysis

Debt Level: 7779's debt to equity ratio (0.2%) is considered satisfactory.

Reducing Debt: 7779's debt to equity ratio has reduced from 72.7% to 0.2% over the past 5 years.

Debt Coverage: 7779's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 7779's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is CYBERDYNE current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 7779's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 7779's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 7779's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 7779's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 7779's dividend in 3 years as they are not forecast to pay a notable one for the JP market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.9yrs

Average board tenure


CEO

Yoshiyuki Sankai (62 yo)

14.92yrs

Tenure

Mr. Yoshiyuki Sankai has been the President and Chief Executive Officer of CYBERDYNE Inc. since February 2006 and also serves as its Chairman. Mr. Sankai established CYBERDYNE, Inc. in June 2004. He has be...


Board Members

NamePositionTenureCompensationOwnership
Yoshiyuki Sankai
Chairman14.92yrsno data37.53%
¥ 52.0b
Fumiyuki Ichihashi
Team Leader of Information Strategy Team & Director16.58yrsno datano data
Shinji Uga
Head of Corporate Unit & Director11.92yrsno data0.028%
¥ 38.6m
Cees Vellekoop
Outside Audit & Supervisory Board Member13.58yrsno datano data
Hikari Imai
Independent Outside Director5.58yrsno datano data
Kazumasa Yoshida
Independent Outside Director7.58yrsno data0.028%
¥ 38.6m
Kenichiro Okamura
Outside Audit & Supervisory Board Member9.58yrsno datano data
Hiroaki Kawamoto
Director16.58yrsno data0.0065%
¥ 9.0m
Kinichi Nakata
Independent Outside Director12.58yrsno datano data
Yutaka Fujitani
Outside Audit & Supervisory Board Member (Full-Time)9.58yrsno datano data

11.9yrs

Average Tenure

60yo

Average Age

Experienced Board: 7779's board of directors are seasoned and experienced ( 11.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CYBERDYNE Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CYBERDYNE Inc.
  • Ticker: 7779
  • Exchange: TSE
  • Founded: 2004
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥138.548b
  • Shares outstanding: 215.14m
  • Website: https://www.cyberdyne.jp

Number of Employees


Location

  • CYBERDYNE Inc.
  • 2-2-1, Gakuen-Minami
  • Tsukuba
  • Ibaraki
  • 305-0818
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7779TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYMar 2014
8C4DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2014
CYBQ.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2014
CYBQ.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDOct 2015

Biography

CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/20 08:08
End of Day Share Price2021/01/20 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.